BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Axelrad JE, Roy A, Lawlor G, Korelitz B, Lichtiger S. Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective. World J Gastroenterol 2016; 22(46): 10103-10117 [PMID: 28028358 DOI: 10.3748/wjg.v22.i46.10103]
URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10103.htm
Number Citing Articles
1
Benoit Follin-Arbelet, Milada Cvancarova Småstuen, Øistein Hovde, Lars-Petter Jelsness-Jørgensen, Bjørn Moum. Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study)Journal of Crohn's and Colitis 2023; 17(4): 497 doi: 10.1093/ecco-jcc/jjac156
2
Kendra Kamp, Amanda Holmstrom, Zhehui Luo, Gwen Wyatt, Barbara Given. Factors Influencing Received Social Support Among Emerging Adults With Inflammatory Bowel DiseaseGastroenterology Nursing 2020; 43(6): 429 doi: 10.1097/SGA.0000000000000483
3
Anton Risto, Maie Abdalla, Pär Myrelid. Staging Pouch Surgery in Ulcerative Colitis in the Biological EraClinics in Colon and Rectal Surgery 2022; 35(01): 058 doi: 10.1055/s-0041-1740039
4
Giovanni Clemente Actis, Rinaldo Pellicano, Davide Giuseppe Ribaldone. A Concise History of Thiopurines for Inflammatory Bowel Disease: From Anecdotal Reporting to Treat-to-Target AlgorithmsReviews on Recent Clinical Trials 2019; 14(1): 4 doi: 10.2174/1574887113666180910120959
5
Paula Sousa, Paula Ministro, Alessandro Armuzzi, Axel Dignass, Marte Lie Høivik, Manuel Barreiro-de Acosta, Stephan Vavricka, Rogério Saad-Hossne, Paulo Gustavo Kotze, Laurent Peyrin-Biroulet, Fernando Magro. Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel diseaseDigestive and Liver Disease 2021; 53(12): 1571 doi: 10.1016/j.dld.2021.05.038
6
Anuraag Jena, Chhagan L Birda, Arup Choudhury, Vishal Sharma. Safety and efficacy of personalized versus standard initial dosing of thiopurines: Systematic review and meta-analysis of randomized trialsExpert Opinion on Drug Safety 2023; 22(12): 1253 doi: 10.1080/14740338.2023.2236554
7
Qing Zhou, Zhao-Feng Shen, Ben-sheng Wu, Cheng-biao Xu, Zhong-qi He, Tuo Chen, Hong-tao Shang, Chao-fan Xie, Si-yi Huang, Yu-gen Chen, Hai-bo Chen, Shu-tang Han. Risk of Colorectal Cancer in Ulcerative Colitis Patients: A Systematic Review and Meta-AnalysisGastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/5363261
8
Ji Young Chang, Jae Hee Cheon. Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and PharmacogeneticsDigestive Diseases and Sciences 2019; 64(9): 2395 doi: 10.1007/s10620-019-05720-5
9
Grant E. Barber, Steven Hendler, Monica Choe, Kian Keyashian, Sarah Lechner, Berkeley N. Limketkai, David Limsui. Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel DiseaseDigestive Diseases and Sciences 2022; 67(4): 1287 doi: 10.1007/s10620-021-06947-x
10
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disordersWorld Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
11
Christopher J Burgess, Claire Reilly, Lana Steward-Harrison, Fariha Balouch, Peter J Lewindon. Utility of proactive infliximab levels in paediatric Crohn’s diseaseArchives of Disease in Childhood 2019; 104(3): 251 doi: 10.1136/archdischild-2018-315100
12
Michael W. Winter, Joel V. Weinstock. The Autoimmune Diseases2020; : 871 doi: 10.1016/B978-0-12-812102-3.00046-4
13
Margarita L. Martinez-Fierro, Idalia Garza-Veloz, Maria R. Rocha-Pizaña, Edith Cardenas-Vargas, Miguel A. Cid-Baez, Fabiola Trejo-Vazquez, Virginia Flores-Morales, Gabriela A. Villela-Ramirez, Ivan Delgado-Enciso, Iram P. Rodriguez-Sanchez, Yolanda Ortiz-Castro. Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel diseaseMedicine 2019; 98(38): e17208 doi: 10.1097/MD.0000000000017208
14
Katherine R. Baldwin, Jess L. Kaplan. Medical management of pediatric inflammatory bowel diseaseSeminars in Pediatric Surgery 2017; 26(6): 360 doi: 10.1053/j.sempedsurg.2017.10.005
15
Erik Munnig-Schmidt, Mei Zhang, Chris J Mulder, Murray L Barclay. Late-onset Rise of 6-MMP Metabolites in IBD Patients on Azathioprine or MercaptopurineInflammatory Bowel Diseases 2018; 24(4): 892 doi: 10.1093/ibd/izx081
16
Ewa Dudzińska, Magdalena Gryzinska, Katarzyna Ognik, Paulina Gil-Kulik, Janusz Kocki. Oxidative Stress and Effect of Treatment on the Oxidation Product Decomposition Processes in IBDOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/7918261
17
Marcel Vetter, Markus F. Neurath. Treatment Perspectives in Crohn’s DiseaseDigestion 2018; 98(3): 135 doi: 10.1159/000488449
18
Karam Devi, Anjana Bali, Pankaj Bhatia, Nirmal Singh, Amteshwar Singh Jaggi. Exploring the ameliorative potential of Bacopa monnieri in acetic acid induced ulcerative colitis in miceNatural Product Research 2023; : 1 doi: 10.1080/14786419.2023.2233047
19
Sydney Solomon, Eunie Park, Joseph A. Picoraro. Making Decisions about Dietary Therapy in Inflammatory Bowel DiseaseGastrointestinal Disorders 2020; 2(4): 353 doi: 10.3390/gidisord2040032
20
Gonzalo Saiz-Gonzalo, Naomi Hanrahan, Valerio Rossini, Raminder Singh, Mary Ahern, Maebh Kelleher, Shane Hill, Ruairi O’Sullivan, Aine Fanning, Patrick T. Walsh, Seamus Hussey, Fergus Shanahan, Ken Nally, Caitriona M. O’Driscoll, Silvia Melgar. Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD PathogenesisFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.655960
21
Sofía Frigerio, Dalia A. Lartey, Geert R. D’Haens, Joep Grootjans. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic MechanismsInternational Journal of Molecular Sciences 2021; 22(23): 12739 doi: 10.3390/ijms222312739
22
Teuta Gjuladin-Hellon, Zipporah Iheozor-Ejiofor, Morris Gordon, Anthony K Akobeng. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's diseaseCochrane Database of Systematic Reviews 2019; 2019(8) doi: 10.1002/14651858.CD010233.pub3
23
Rasmus Rankala, Anssi Mustonen, Markku Voutilainen, Kalle Mattila. Costs of medications used to treat inflammatory bowel diseaseScandinavian Journal of Gastroenterology 2024; 59(1): 34 doi: 10.1080/00365521.2023.2248539
24
Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai. Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?International Immunopharmacology 2023; 116: 109597 doi: 10.1016/j.intimp.2022.109597
25
Natália Oliveira e Silva, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Maria Luísa Cordeiro Santos, Fabrício Freire de Melo. Probiotics in inflammatory bowel disease: Does it work?World Journal of Meta-Analysis 2020; 8(2): 54-66 doi: 10.13105/wjma.v8.i2.54
26
Taku Kobayashi, Eri Udagawa, Toshifumi Hibi. Lack of Increased Risk of Lymphoma with Thiopurine Therapy Regardless of Dose and Duration of Treatment in Japanese Patients with Inflammatory Bowel DiseasesDigestion 2022; 103(2): 169 doi: 10.1159/000519560
27
Caroline Di Jiang, Tim Raine. IBD considerations in spondyloarthritisTherapeutic Advances in Musculoskeletal Disease 2020; 12: 1759720X2093941 doi: 10.1177/1759720X20939410
28
Maria Francesca Russo, Annalisa Diddoro, Alessandra Iodice, Carola Severi, Lidia Castagneto-Gissey, Giovanni Casella. Incidence of lymphomas in inflammatory bowel disease: report of an emblematic case, systematic review, and meta-analysisFrontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1172634
29
Carla J. Gargallo-Puyuelo, Viviana Laredo, Fernando Gomollón. Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.681907
30
Mireya Ramirez-Florencio, Silvia Jiménez-Morales, Rosa Elda Barbosa-Cobos, Daniela Josabeth López-Cano, Julian Ramírez-Bello. High frequency of mutant thiopurine S-methyltransferase genotypes in Mexican patients with systemic lupus erythematosus and rheumatoid arthritisClinical Rheumatology 2018; 37(4): 963 doi: 10.1007/s10067-017-3955-4
31
Anja Eberl, Taru Hallinen, Clas-Göran af Björkesten, Markku Heikkinen, Eija Hirsi, Mikko Kellokumpu, Inka Koskinen, Veikko Moilanen, Christian Nielsen, Heikki Nuutinen, Ulla-Maija Suhonen, Karri Utriainen, Ilkka Vihriälä, Erkki Soini, Christina Wennerström, Riikka Nissinen, Andras Borsi, Minni Koivunen, Jyrki Tillonen, Taina Sipponen. Ustekinumab for Crohn’s disease: a nationwide real-life cohort study from Finland (FINUSTE)Scandinavian Journal of Gastroenterology 2019; 54(6): 718 doi: 10.1080/00365521.2019.1624817
32
Yong Hua Sheng, Rabina Giri, Julie Davies, Veronika Schreiber, Saleh Alabbas, Ramya Movva, Yaowu He, Andy Wu, John Hooper, Brett McWhinney, Iulia Oancea, Gregor Kijanka, Sumaira Hasnain, Andrew J. Lucke, David P. Fairlie, Michael A. McGuckin, Timothy H. Florin, Jakob Begun. A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and AutophagyCellular and Molecular Gastroenterology and Hepatology 2021; 11(1): 33 doi: 10.1016/j.jcmgh.2020.05.012
33
Jack S. Cornish, Elisa Wirthgen, Jan Däbritz. Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel DiseaseFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00008
34
Takahiro Ito, Atsuo Maemoto, Takehiko Katsurada, Hiroki Tanaka, Satoshi Motoya, Nobuhiro Ueno, Mikihiro Fujiya, Toshifumi Ashida, Daisuke Hirayama, Hiroshi Nakase. Long-Term Clinical Effectiveness of Ustekinumab in Patients With Crohn’s Disease: A Retrospective Cohort StudyCrohn's & Colitis 360 2020; 2(4) doi: 10.1093/crocol/otaa061
35
Taina Sipponen, Clas-Göran af Björkesten, Taru Hallinen, Tuire Ilus, Erkki Soini, Anja Eberl, Mikko Heikura, Mikko Kellokumpu, Ritva Koskela, Christian Nielsen, Heikki Nuutinen, Markku Heikkinen, Ulla-Maija Suhonen, Jyrki Tillonen, E. Christina M. Wennerström, Andras Borsi, Minni R. Koivunen. A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn’s disease patients in FinlandScandinavian Journal of Gastroenterology 2021; 56(6): 661 doi: 10.1080/00365521.2021.1906315
36
Jason Reinglas, Lorant Gonczi, Zsuzsanna Kurt, Talat Bessissow, Peter L Lakatos. Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseasesWorld Journal of Gastroenterology 2018; 24(32): 3567-3582 doi: 10.3748/wjg.v24.i32.3567
37
Silvio Danese, Markus F. Neurath, Adam Kopoń, Salam F. Zakko, Timothy C. Simmons, Ronald Fogel, Corey A. Siegel, Remo Panaccione, Xiaojiang Zhan, Keith Usiskin, Denesh Chitkara. Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative ColitisClinical Gastroenterology and Hepatology 2020; 18(11): 2526 doi: 10.1016/j.cgh.2019.12.032